Last reviewed · How we verify
NCT05946746
The Effects of PeptiStrong and Exercise to Enhance Muscle Strength in Young Subjects
NA trial testing PeptiStrong in Muscle Injury in 72 participants. Completed in 23 May 2024.
23 January 2024
Quick facts
| Lead sponsor | Nuritas Ltd |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 72 |
| Start date | 9 August 2023 |
| Primary completion | 23 January 2024 |
| Estimated completion | 23 May 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- PeptiStrong
- Placebo SMCC silicated micro-crystalline cellulose
Conditions studied
- Muscle Injury — all drugs for Muscle Injury →
Sponsor
Nuritas Ltd
Who can join
Adults 19 to 40, any sex, with Muscle Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomised, double-blind, placebo controlled study to evaluate the effect of PeptiStrong supplementation in conjunction with an exercise program to enhance muscle strength and endurance in young male and female subjects.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Randomised, double-blind, placebo-controlled study to evaluate the effect on human strength and endurance after resistance training and supplementation of Vicia faba protein hydrolysate compared with placebo.
Mohan NM, Khaldi N, Keogh B, Franklyn Miller A. · · 2025 · PMID 40771513 · DOI 10.1136/bmjnph-2024-001050
Verify or expand the search:
- PubMed search for NCT05946746
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscle Injury
Currently open trials in the same condition.
- NCT05746650 — Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury · NA · recruiting
- NCT05344183 — Immediate and Short-term Effects of Low-level Laser · NA · active not recruiting
- NCT03660969 — Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease · active not recruiting
Other Nuritas Ltd trials
Trials by the same sponsor.
- NCT07528469 — The Effects of PeptiStrong and Whey on Muscle Function In Older Adults · NA · not yet recruiting
- NCT07258433 — Effects of PeptiSleep on Sleep Quality in Healthy Adults · NA · recruiting
- NCT07322653 — The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population · NA · recruiting
- NCT06894875 — Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance · NA · recruiting
- NCT06440213 — A Study to Determine the Safety and Tolerability of a Range of Doses of PeptiControl in Pre-diabetic Individuals · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05946746 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nuritas Ltd
- Last refreshed: 20 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05946746.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing